---
$id: https://graph.org.ai/products/commodity/51432901
$type: Product
source: UNSPSC
code: "51432901"
title: "Belfosdil"
class: "51432900"
classTitle: "Antihypertensive organophosphorus compounds"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Belfosdil

**UNSPSC Code**: 51432901
**Class**: [Antihypertensive organophosphorus compounds](Antihypertensive organophosphorus compounds.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a calcium channel blocker with the molecular formula C27H50O7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W91CMS1V7Z, chemically known as phosphonic acid, (2-(2-phenoxyethyl)-1,3-propanediyl)bis-, tetrabutyl ester but generally known as belfosdil, which bears US NIH Compound Identifier 72122. European Medicines Agency schedules Belfosdil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05687MIG. The term BELFOSDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). BELFOSDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BELFOSDIL remains the US FDA Preferred Term for this commodity. Belfosdil bears US NLM identifiers UMLS ID C0053078 and NCI Concept Code C76023. SMILES: P(=O)(OCCCC)(OCCCC)CC(CP(=O)(OCCCC)OCCCC)CCOc1ccccc1.

